Current Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2021 - Present
Medicine, Medical Oncology,
Medicine
Recent Publications
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
Journal Article Prostate Cancer Prostatic Dis · June 2025 Combined androgen deprivation therapy (ADT) and radiotherapy (RT) improves outcomes for intermediate and high-risk prostate cancer. Treatment intensification with abiraterone acetate/prednisone (AAP) provides additional benefit for high-risk disease. We pr ... Full text Link to item CiteSystemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
Journal Article J Clin Oncol · May 2, 2025 PURPOSE: To provide evidence-based recommendations for patients with metastatic castration-resistant prostate cancer (mCRPC). METHODS: An Expert Panel including patient representation completed a systematic review of the evidence and made recommendations. ... Full text Link to item CiteAuthor Correction: Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.
Journal Article Nat Biomed Eng · May 2025 Full text Link to item CiteRecent Grants
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
Clinical TrialSignificant Contributor · Awarded by National Institutes of Health · 2014 - 2023Predicting patient-specific responses to personalize androgen deprivation therapy for prostate cancer
ResearchPrincipal Investigator · Awarded by H. Lee Moffitt Cancer Center & Research Institute · 2019 - 2022Conditional lethality of copper and disulfiram as a therapeutic modality for prostate cancer
ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2016 - 2022View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2019
M.H.S.
Harvard Medical School ·
2009
M.D.